Skip to content

Management of Amavata(Rhumatoid Arthritis) with Modified Patch

A Randomised Comparative Clinical Study To Evaluate The Efficacy Of Doshghna Lepa And Modified Doshghna Patch As An Adjuvant Therapy In The Management Of Amavata W.S.R.To Rheumatoid Arthritis - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067429
Enrollment
40
Registered
2024-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified Health Condition 2: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

Parul Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with previously or newly diagnosed case of Amavata Amavata patients between the age group of 18 to 60 years Patients of either Gender irrespective of caste or religion Patient having pain and swelling over large joints only

Exclusion criteria

Exclusion criteria: Patients of age below 18 years and above 60 years of either sex Patients having other systemic disorders carcinoma,Rheumatoid heart disease Tuberculosis,Infectitious diseases,and otherlife threatening disorders

Design outcomes

Primary

MeasureTime frame
To Develop the modified Doshghna patchTimepoint: 30 days

Secondary

MeasureTime frame
To study the efficacy of Doshghna lepa in the management of Amavata To study the efficacy of modified Doshghna patch in the management of Amavata To compare the efficacy of Doshghna lepa and modified Doshghna patch in the management of AmavataTimepoint: 14 Days

Countries

India

Contacts

Public ContactDr Sangeeta H Toshikhane

Parul Ayurved Hospital

sangeeta.toshikhane26791@paruluniversity.ac.in9964596479

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026